Abstract

APPROVED COVID 19 VACCINES: A REVIEW

Jaya Sahebrao Gharate*, Sagar Anil Daitkar and Komal Anil Aher

.

Abstract

The purpose of the review: To update the knowledge of nations regarding approved covid 19 vaccines by Emergency Use Authorization (EUA). To bring awareness in the community about the kind of vaccine, their mechanism of action, administration route, effective dosing, observed side effects and storage conditions. This article represents the essential data about covid 19 vaccines. COVID- 19 has affected millions of people and put an unparalleled burden on healthcare systems as well as economies throughout the world. Currently, there is no decisive therapy for COVID-19 or related complications. The only hope to mitigate this pandemic is through vaccines. The COVID-19 vaccines are being developed rapidly, compared to traditional vaccines, and are being approved via Emergency Use Authorization (EUA) worldwide. So far, there are 232 vaccine candidates. One hundred and seventy-two are in preclinical development and 60 in clinical development, of which 10 are approved under EUA by different countries. This includes the United Kingdom (UK), United States of America (USA), Canada, Russia, China, Australia and India.[1] The article contains COVID- 19 vaccines authorized/approved for emergence use as of February 28, 2021.

Keywords: BNT162, mRNA-1273, AZD1222 by AstraZeneca, CoronaVac by Sinovac, Sinopharm and the Wuhan Institute of Virology China, Sputnik V, BBIBP-CorV, EpiVacCorona, covaxin, Janssen.